Results of epidemiological surveillance in a surgical intensive care unit: a prospective single-center study

Authors:

Abstract
Objective. To evaluate the trends in healthcare-associated infection (HAI) rates and analyze the effectiveness of the infection control system in a surgical anesthesiology and intensive care unit (ICU) among patients undergoing abdominal surgeries and liver or kidney transplantation. Materials and methods. A single-center prospective study was conducted at the ICU of the Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology. Over the period from 2019 to 2025, a total of 10,567 patients were treated (82.2 % – surgical profile, 30.6 % – post-transplant recipients). Epidemiological surveillance included registration of HAIs using standard case definitions, microbiological monitoring, and assessment of antimicrobial resistance. Data processing was performed using WHONET 5.6 and IBM SPSS Statistics 26.0 software. Results. The overall incidence of healthcare-associated infections (HAIs) peaked in 2021 at 12.5 (95 % CI (9.7–15.5)) per 100 patients, then decreased to 5.6 in 2022 and stabilized in 2023–2025 at 4.6–5.9 per 100 treated patients. The rate of ventilatorassociated pneumonia decreased from 27.3 (2021) to 12.8 (2025) per 1000 ventilator-days (p = 0.04). The rate of surgical site infections decreased from 1.0 (2019) to 0.5 (2025) per 100 operations (p = 0.03). A shift in the timing of late-onset infections was noted (VAP – on day 10 of mechanical ventilation, CAUTI – on day 13 of catheterization). An increase in the proportion of Gram-positive flora (from 25 to 33 %, p = 0.06) and Candida fungi ( Candida non-albicans – 58%, including C. auris – 31 %) was revealed. The proportion of imported cases was 21% (95 % CI (16.7–25.9)). An increase in the susceptibility of major Gram-negative pathogens to carbapenems and polymyxins was observed (p < 0.05 for most comparisons). Conclusion. The implementation of epidemiological surveillance, adherence to infection control measures, and optimization of antimicrobial therapy are associated with a reduction in HAI incidence and the prevalence of carbapenem-resistant microorganisms, as well as with a mitigation of the consequences of imported epidemiologically significant pathogens.

This publication has 9 references indexed in Scilit: